J W Janni

Summary

Affiliation: University of Munich
Country: Germany

Publications

  1. pmc Prognostic relevance of disseminated tumor cells in the bone marrow and biological factors of 265 primary breast carcinomas
    Christian Schindlbeck
    1st Department of Obstetrics and Gynecology Klinikum, Ludwig Maximilians University, D 80337 Munich, Germany
    Breast Cancer Res 7:R1174-85. 2005
  2. ncbi Prognostic impact of Thomsen-Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients
    Christian Schindlbeck
    First Department of Obstetrics and Gynecology, Ludwig Maximilians University of Munich, Maistrasse 11, D 80337, Munich, Germany
    Breast Cancer Res Treat 101:17-25. 2007
  3. ncbi The prognostic impact of a prolonged second stage of labor on maternal and fetal outcome
    Wolfgang Janni
    Department of Obstetrics and Gynecology, Central Hospital of Ludwig Maximilians University, Maistrasse 11, 80337 Munich, Germany
    Acta Obstet Gynecol Scand 81:214-21. 2002
  4. ncbi [Chemotherapy-associated enterocolitis--a rare but potentially lethal side effect of adjuvant breast cancer treatment: a case report]
    J W Janni
    I Frauenklinik, Klinikum der Ludwig Maximilians Universität, Maistrasse 11, DE 80337 Munich, Germany
    Gynakol Geburtshilfliche Rundsch 44:240-3. 2004
  5. ncbi Intra-mammary tumor location does not influence prognosis but influences the prevalence of axillary lymph-node metastases
    Wolfgang Janni
    Department of Gynecology and Obstetrics, University Hospital, Ludwig Maximilians University, Maistrasse 11, 80337, Munich, Germany
    J Cancer Res Clin Oncol 129:503-10. 2003
  6. ncbi The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence
    Wolfgang Janni
    I Frauenklinik, Klinikum der Ludwig Maximilians Universtitaet, Muenchen, Germany
    Cancer 103:884-91. 2005
  7. ncbi [Progress in the early diagnosis of breast carcinoma during the years 1981-1990. Results of a longitudinal study]
    W Janni
    I Frauenklinik, Klinikum der Ludwig Maximilians Universität München, Munich
    Dtsch Med Wochenschr 128:601-6. 2003
  8. ncbi Patterns of disease recurrence influenced by hematogenous tumor cell dissemination in patients with cervical carcinoma of the uterus
    Wolfgang Janni
    Department of Gynecology and Obstetrics, I Frauenklinik, Klinikum der Ludwig Maximilians Universtitaet, Muenchen, Germany
    Cancer 97:405-11. 2003
  9. ncbi [Chemotherapy-associated myelosuppression in gynecological oncology]
    W Janni
    1 Frauenklinik, Klinikum der Ludwig Maximilians Universität, Munchen, Deutschland
    Gynakol Geburtshilfliche Rundsch 41:166-73. 2001
  10. ncbi Clinical relevance of occult metastatic cells in the bone marrow of patients with different stages of breast cancer
    W Janni
    I Frauenklinik, Klinikum Innenstadt, Ludwig Maximilians Universitat, Munich, Germany
    Clin Breast Cancer 1:217-25. 2000

Detail Information

Publications58

  1. pmc Prognostic relevance of disseminated tumor cells in the bone marrow and biological factors of 265 primary breast carcinomas
    Christian Schindlbeck
    1st Department of Obstetrics and Gynecology Klinikum, Ludwig Maximilians University, D 80337 Munich, Germany
    Breast Cancer Res 7:R1174-85. 2005
    ..We therefore examined 'tissue micro arrays' (TMAs) of 265 primary breast carcinomas from patients with known bone marrow (BM) status for HER2, Topoisomerase IIalpha (Top IIa), Ki 67, and p53...
  2. ncbi Prognostic impact of Thomsen-Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients
    Christian Schindlbeck
    First Department of Obstetrics and Gynecology, Ludwig Maximilians University of Munich, Maistrasse 11, D 80337, Munich, Germany
    Breast Cancer Res Treat 101:17-25. 2007
    ..We examined the expression of TF in primary breast cancer tissue of 265 patients with known BM status at the time of first diagnosis...
  3. ncbi The prognostic impact of a prolonged second stage of labor on maternal and fetal outcome
    Wolfgang Janni
    Department of Obstetrics and Gynecology, Central Hospital of Ludwig Maximilians University, Maistrasse 11, 80337 Munich, Germany
    Acta Obstet Gynecol Scand 81:214-21. 2002
    ..The purpose of this study was to evaluate the effect of the duration of labor on fetal distress and maternal perinatal morbidity...
  4. ncbi [Chemotherapy-associated enterocolitis--a rare but potentially lethal side effect of adjuvant breast cancer treatment: a case report]
    J W Janni
    I Frauenklinik, Klinikum der Ludwig Maximilians Universität, Maistrasse 11, DE 80337 Munich, Germany
    Gynakol Geburtshilfliche Rundsch 44:240-3. 2004
    ..Four days after the second cycle of docetaxel, the patient presented with abdominal pain, nausea, vomiting and obstipation of 3 days' duration...
  5. ncbi Intra-mammary tumor location does not influence prognosis but influences the prevalence of axillary lymph-node metastases
    Wolfgang Janni
    Department of Gynecology and Obstetrics, University Hospital, Ludwig Maximilians University, Maistrasse 11, 80337, Munich, Germany
    J Cancer Res Clin Oncol 129:503-10. 2003
    ....
  6. ncbi The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence
    Wolfgang Janni
    I Frauenklinik, Klinikum der Ludwig Maximilians Universtitaet, Muenchen, Germany
    Cancer 103:884-91. 2005
    ..If the persistence of ITCs after adjuvant therapy confers a similar risk for recurrence, then it would be an indication to consider secondary adjuvant therapy...
  7. ncbi [Progress in the early diagnosis of breast carcinoma during the years 1981-1990. Results of a longitudinal study]
    W Janni
    I Frauenklinik, Klinikum der Ludwig Maximilians Universität München, Munich
    Dtsch Med Wochenschr 128:601-6. 2003
    ..This study investigated whether efforts at early diagnosis of cancer in the 1980s have had an effect on average tumor size at first diagnosis and on survival rate...
  8. ncbi Patterns of disease recurrence influenced by hematogenous tumor cell dissemination in patients with cervical carcinoma of the uterus
    Wolfgang Janni
    Department of Gynecology and Obstetrics, I Frauenklinik, Klinikum der Ludwig Maximilians Universtitaet, Muenchen, Germany
    Cancer 97:405-11. 2003
    ..This study evaluates the prevalence and prognostic significance of ITC in patients with primary carcinoma of the cervix uteri...
  9. ncbi [Chemotherapy-associated myelosuppression in gynecological oncology]
    W Janni
    1 Frauenklinik, Klinikum der Ludwig Maximilians Universität, Munchen, Deutschland
    Gynakol Geburtshilfliche Rundsch 41:166-73. 2001
    ..The aim of this study was to compare - in our own patient population - the chemotherapy-associated myelosuppression of four chemotherapeutic regimens used in gynecological oncology...
  10. ncbi Clinical relevance of occult metastatic cells in the bone marrow of patients with different stages of breast cancer
    W Janni
    I Frauenklinik, Klinikum Innenstadt, Ludwig Maximilians Universitat, Munich, Germany
    Clin Breast Cancer 1:217-25. 2000
    ..The present review also focuses on state of the art, reliable detection methods of occult metastatic cells in the bone marrow of breast cancer patients and on the prognostic relevance of these cells at different stages of the disease...
  11. ncbi [The influence of the hemoglobin concentration on the hematogenous tumor cell dissemination at the time of the initial diagnosis of breast cancer]
    W Janni
    I Frauenklinik, Klinikum der Ludwig Maximilians Universtität München, Germany
    Dtsch Med Wochenschr 127:71-7. 2002
    ....
  12. ncbi Matched pair analysis of survival after chest-wall recurrence compared to mammary recurrence: a long-term follow up
    W Janni
    Department of Gynecology and Obstetrics, Klinikum Innenstadt, Ludwig Maximilians Universität Muenchen, Germany
    J Cancer Res Clin Oncol 127:455-62. 2001
    ....
  13. ncbi Quality of life influenced by primary surgical treatment for stage I-III breast cancer-long-term follow-up of a matched-pair analysis
    W Janni
    Department of Gynecology and Obstetrics, Women s Clinic at Ludwig Maximilians University, Munich, Germany
    Ann Surg Oncol 8:542-8. 2001
    ..The purpose of the present study is to compare the long-term impact of these two surgical approaches on QOL in patients with identical tumor stages and to suggest possible shortcomings of the standard QOL questionnaires...
  14. ncbi The fate and prognostic value of occult metastatic cells in the bone marrow of patients with breast carcinoma between primary treatment and recurrence
    W Janni
    I Frauenklinik, Klinikum der Ludwig Maximilians Universtitaet, Muenchen, Germany
    Cancer 92:46-53. 2001
    ....
  15. ncbi Radiotherapy of the chest wall following mastectomy for early-stage breast cancer: impact on local recurrence and overall survival
    W Janni
    I Frauenklinik, Ludwig Maximilians Universtitaet, Maistr 11, D 80337, Muenchen, Germany
    Int J Radiat Oncol Biol Phys 48:967-75. 2000
    ..This study was designed to clarify whether or not routine radiotherapy of the chest wall following mastectomy reduces the risk of local recurrence and if it influences the overall survival rate...
  16. ncbi [Prospective randomized study comparing the effectiveness and tolerance of various low-molecular-weight heparins in high risk patients]
    W Janni
    Frauenklinik, Klinikum Innenstadt, Ludwig Maximilians Universitat, Munchen
    Zentralbl Chir 126:32-8. 2001
    ..However, different LMWHs vary significantly in their pharmacokinetic profile and bioavailability pattern. It remains unknown, whether these pharmacological differences result in a clinically divergent behavior...
  17. ncbi Occult tumor cells in bone marrow of patients with locoregionally restricted ovarian cancer predict early distant metastatic relapse
    S Braun
    I Frauenklinik and Institute of Immunology, Ludwig Maximilians Universitat Munchen, Munich, Germany
    J Clin Oncol 19:368-75. 2001
    ..Consequently, we investigated the incidence of early hematogenous dissemination and its association with distant disease-free and overall survival...
  18. ncbi Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy
    S Braun
    I Frauenklinik and Department of Gynecological Pathology, Klinikum Innenstadt, Ludwig Maximilians University, Munchen, Gemany
    J Clin Oncol 19:1468-75. 2001
    ..In the present study we analyzed whether a correlation exists between microscopic tumor cell spread to bone marrow and to lymph nodes and attempted to determine which route is clinically more important...
  19. ncbi Impact of medical and demographic factors on long-term quality of life and body image of breast cancer patients
    K Hartl
    I Frauenklinik, Klinikum der Ludwig Maximilians Universität München, Munich, Germany
    Ann Oncol 14:1064-71. 2003
    ..We investigated the influence of six different factors on long-term QoL and body image of women with primary breast cancer...
  20. ncbi Obstetrical parameters influencing the duration of the second stage of labor
    B Schiessl
    Prenatal Medicine Unit, Department of Obstetrics and Gynaecology, Ludwig Maximilians University, Maistr 11, 80337 Munich, Germany
    Eur J Obstet Gynecol Reprod Biol 118:17-20. 2005
    ..To investigate the impact of parameters influencing the duration of the second stage of labor in vaginal deliveries...
  21. ncbi [Treatment of pregnancy associated gynaecological malignancies]
    W Janni
    I Frauenklinik Innenstadt, Klinikum der Ludwig Maximilians Universtität München
    Zentralbl Gynakol 128:129-34. 2006
    ..For these reasons, special features of the diagnosis and treatment of gynaecological malignancies will regularly part of routine patient care. This review article covers certain practice related features of gynaecological malignancies...
  22. ncbi [A perioperative screening for metastatic disease is not indicated in patients with primary breast cancer and no clinical signs of tumor spread]
    B Gerber
    I Frauenklinik der Ludwig Maximilians Universität München, Munchen
    Zentralbl Gynakol 126:275-9. 2004
    ..Is a perioperative metastatic screening programme indicated in patients presenting with primary operable breast cancer and no signs of distant metastases?..
  23. ncbi Inhibin A is down-regulated during chemotherapy in patients with breast cancer
    N Burkhardt
    First Department of Obstetrics and Gynaecology, Ludwig Maximilians University Munich, Munich, Germany
    Anticancer Res 30:4563-6. 2010
    ..Aims of this study were to determine the serological measurement of inhibin A (α-βA) in breast cancer patients during chemotherapy...
  24. ncbi Study participation improves treatment strategies and individual patient care in participating centers
    W Janni
    Frauenklinik Innenstadt of the LMU Munich, Germany
    Anticancer Res 26:3661-7. 2006
    ..With a median recruitment of 33 patients per month at 198 actively-recruiting centers, the ADEBAR study was the best recruiting study in Germany until the end of the trial...
  25. ncbi Prognostic impact of KI67, p53, human epithelial growth factor receptor 2, topoisomerase IIalpha, epidermal growth factor receptor, and nm23 expression of ovarian carcinomas and disseminated tumor cells in the bone marrow
    C Schindlbeck
    First Department of Obstetrics and Gynecology, Ludwig Maximilians University of Munich, Munich, Germany
    Int J Gynecol Cancer 17:1047-55. 2007
    ..However, even in advanced stages, examination of tumor biological factors could help to stratify subgroups of patients and establish targeted therapies...
  26. ncbi Isolated tumor cells in the bone marrow (ITC-BM) of breast cancer patients before and after anthracyclin based therapy: influenced by the HER2- and Topoisomerase IIalpha-status of the primary tumor?
    C Schindlbeck
    I Frauenklinik, Klinikum der Ludwig Maximilians Universität, Maistrasse 11, 80337 Munich, Germany
    J Cancer Res Clin Oncol 131:539-46. 2005
    ....
  27. ncbi Quality of life among breast cancer patients undergoing autologous breast reconstruction versus breast conserving therapy
    D Dian
    University Hospital Munich, Munich, Germany
    J Cancer Res Clin Oncol 133:247-52. 2007
    ..This study was performed to evaluate the difference in the health-related quality of life following breast conserving surgery and autologous breast reconstruction after mastectomy...
  28. ncbi [Report from the 40th annual general meeting of the american society of clinical oncology]
    B Gerber
    I Frauenklinik Innenstadt der Ludwig Maximilians Universität München
    Zentralbl Gynakol 126:259-68. 2004
    ..This is a report about the annual ASCO 2004 with respect to clinical highlights of breast cancer, ovarian, endometrial and cervical cancer...
  29. ncbi Comparative analysis between the HER2 status in primary breast cancer tissue and the detection of isolated tumor cells in the bone marrow
    C Schindlbeck
    I Frauenklinik, Klinikum Ludwig Maximilians University, Munich, Germany
    Breast Cancer Res Treat 87:65-74. 2004
    ..The direct identification of HER2 on ITC-BM is the aim of ongoing research, potentially synergizing the prognostic relevance of ITC-BM and the predictive value of the HER2 status...
  30. ncbi [A randomized, double-blind, placebo-controlled, phase 3 trial comparing SMS 201-995 pa LAR plus tamoxifen versus tamoxifen plus placebo in women with locally recurrent or metastatic breast cancer]
    H Sommer
    Universitäts Frauenklinik Klinikum Innenstadt der LMU München, Germany
    Zentralbl Gynakol 123:557-61. 2001
    ..A randomized, double-blind, placebo-controlled, phase 3 trial comparing SMS 201-995 pa LAR plus tamoxifen versus tamoxifen plus placebo in women with locally recurrent or metastatic breast cancer...
  31. ncbi Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer
    S Braun
    I Frauenklinik, Klinikum Innenstadt, Ludwig Maximilians University, Munich, Germany
    N Engl J Med 342:525-33. 2000
    ..Cytokeratins are specific markers of epithelial cancer cells in bone marrow. We assessed the influence of cytokeratin-positive micrometastases in the bone marrow on the prognosis of women with breast cancer...
  32. ncbi [Tumor biology of primary breast cancer and minimal residual disease]
    C Schindlbeck
    I Frauenklinik, Klinikum der Ludwig Maximilians Universität, Maistrasse 11, D 80337 München, Deutschland
    Acta Med Austriaca Suppl 59:27-31. 2002
    ..Preliminary results on multi colour stained samples indicate that a selection of certain biological factors takes place during tumor cell dissemination...
  33. ncbi [Incidence and prognostic significance of disseminated tumor cells in patients with cervical cancer]
    B Rack
    I Frauenklinik, Klinikum Innenstadt der Ludwig Maximilians Universität, Maistrasse 11, D 80337 München, Deutschland
    Acta Med Austriaca Suppl 59:36-41. 2002
    ..In view of the data on disseminated tumor cells in other tumor entities, these early results might offer new options for refined tumor staging and improved treatment options...
  34. ncbi Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients
    S Braun
    I Frauenklinik der Ludwig Maximilians Universität, Munich, Germany
    J Clin Oncol 18:80-6. 2000
    ..This study was designed to evaluate whether monitoring of micrometastases in bone marrow can predict the response to systemic chemotherapy in breast cancer...
  35. doi [Efficacy of zoledronate in treating persisting isolated tumor cells in bone marrow in patients with breast cancer. A phase II pilot study]
    B Rack
    Klinik fur Frauenheilkunde und Geburtshilfe, Klinikum Innenstadt der Ludwig Maximilians Universität München
    Dtsch Med Wochenschr 133:285-9. 2008
    ..The aim of the present study was to investigate the therapeutic efficacy of zoledronate in reducing persistence of ITC in the bone marrow of patients with breast cancer after they had completed primary therapy...
  36. ncbi Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow
    S Braun
    I Frauenklinik, Klinikum Innenstsdt, Ludwig Maximilians Universitat, Munich, Germany
    Clin Cancer Res 5:3999-4004. 1999
    ..Selection of EpCAM-/ CK+ tumor clones showed that further antibodies directed against tumor-associated antigens are warranted to improve the efficacy of monospecific approaches...
  37. ncbi [Juvenile gigantomastia. Case report and literature survey]
    B Gerber
    I Frauenklinik Innenstadt der Ludwig Maximilians Universität München
    Zentralbl Gynakol 126:167-9. 2004
    ..It is thus suggested that the etiology of this disease might be related to a local hypersensitivity to estrogen. Mediactions (Tamoxifen) are mostly ineffective. The treatment consisted of reduction plasty...
  38. ncbi Complementary and alternative therapeutic approaches in patients with early breast cancer: a systematic review
    B Gerber
    Department of Obstetrics and Gynecology, University of Rostock, Rostock, Germany
    Breast Cancer Res Treat 95:199-209. 2006
    ..We conclude that available data on CAM modalities in the treatment of early-stage breast cancer does not support their application...
  39. ncbi Management of skin-sparing mastectomy: results of a survey of German hospitals
    Darius Dian
    University Women s Clinic of LMU, University Hospital Munich, Maistrasse 11, 80337 Munich, Germany
    Onkologie 29:267-70. 2006
    ..The aim of this study was to evaluate the current management of skin-sparing mastectomy in German hospitals and to determine its oncologic safety. For this purpose, 100 surgeons were surveyed regarding their use of skin-sparing mastectomy...
  40. ncbi Aesthetic result among breast cancer patients undergoing autologous breast reconstruction versus breast conserving therapy
    Darius Dian
    University Hospital Munich, Munich, Germany
    Arch Gynecol Obstet 275:445-50. 2007
    ..Following breast-conserving surgery or mastectomy followed by autologous breast reconstruction, breast cancer patients were studied to discover their satisfaction with the aesthetic results of the two treatment strategies...
  41. ncbi Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system
    Sabine Riethdorf
    Institute of Tumor Biology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    Clin Cancer Res 13:920-8. 2007
    ..Here, we validated the analytic performance of this system for clinical use in patients with metastatic breast cancer...
  42. ncbi Pregnancy-associated breast cancer -- special features in diagnosis and treatment
    Wolfgang Janni
    Obstetrics and Gynecology Clinic and Polyclinic of Ludwig Maximilian University, Klinikum Innenstadt, Munchen, Germany
    Onkologie 29:107-12. 2006
    ..The following article summarizes the special features of the diagnosis and primary therapy of pregnancy-associated breast cancer with particular consideration of cytostatic therapy...
  43. ncbi Influencing factors for regional lymph node recurrence of breast cancer
    Darius Dian
    University Hospital München, Maistrasse 11, Munich, 80337, Germany
    Arch Gynecol Obstet 277:127-34. 2008
    ..We investigated whether the risk of developing regional lymph node recurrence was dependant on the number of lymph nodes removed...
  44. ncbi Comparison of total laparoscopic, vaginal and abdominal hysterectomy
    Christian Schindlbeck
    First Department of Obstetrics and Gynecology, Ludwig Maximilians University of Munich, Maistrasse 11, 80337, Munich, Germany
    Arch Gynecol Obstet 277:331-7. 2008
    ..We analyzed 43 total laparoscopic hysterectomies (TLH) of the years 2005 and 2006 and compared them with 87 vaginal (VH) and 103 abdominal hysterectomies (AH)...
  45. doi Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen
    Christian Schindlbeck
    First Department of Obstetrics and Gynecology, Ludwig Maximilians University of Munich, Munich, Germany
    Clin Exp Metastasis 25:233-40. 2008
    ..Own studies demonstrated a nearly complete TF expression on DTC-BM, indicating its suitability as marker for immunomagnetic enrichment...
  46. ncbi A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation
    Tanja Fehm
    Department of Obstetrics and Gynecology, University of Tubingen, Tubingen, Germany
    Cancer 107:885-92. 2006
    ....
  47. ncbi Minimal residual disease in bone marrow and peripheral blood of patients with metastatic breast cancer
    Joachim Bischoff
    Department of Gynaecology, Okologische Fachklinik Bad Trissl, 83080 Oberaudorf, Germany
    Recent Results Cancer Res 162:135-40. 2003
    ..The immunocytochemical detection of cytokeratin-positive cells in PB seems to be associated with the site of metastatic manifestation...
  48. ncbi Evaluation of bone marrow in breast cancer patients: prediction of clinical outcome and response to therapy
    Stephan Braun
    Department of Ob Gyn, University Hospital, Innsbruck, Austria
    Breast 12:397-404. 2003
    ..Except for promising pilot studies, no data are available to support the immediate use of bone marrow evaluation for treatment monitoring in order to enable the prediction of response to adjuvant therapy...
  49. ncbi Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?
    Brigitte Rack
    Department of Gynecology and Obstetrics, I Frauenklinik, Klinikum der Ludwig Maximilians Universitaet, Munich, Germany
    Breast Cancer Res Treat 82:83-92. 2003
    ..Persisting prognostic impact after relapse would identify lymph node status as a marker for tumor biology, in contrast to a simply time-dependent phenomenon...
  50. ncbi Unexpected metastatic lobular carcinoma of the breast with intraabdominal spread and subsequent port-site metastasis after diagnostic laparoscopy for exclusion of ovarian cancer
    Ioannis Mylonas
    First Department of Obstetrics and Gynecology, Ludwig Maximilians University Munich, Munich 80337, Germany
    Gynecol Oncol 95:405-8. 2004
    ..Although lobular carcinomas metastasize primarily to lymph nodes, bone, lung and liver, they can also spread to the gastrointestinal tract, peritoneum and gynecologic organs...
  51. ncbi Is the histomorphological concept of the female pelvic floor and its changes due to age and vaginal delivery correct?
    Katharina Jundt
    Department of Obstetrics and Gynecology, Maistrasse, Ludwig Maximilians Universitaet, Munich, Germany
    Neurourol Urodyn 24:44-50. 2005
    ....
  52. ncbi Expression of glycodelin protein and mRNA in human ductal breast cancer carcinoma in situ, invasive ductal carcinomas, their lymph node and distant metastases, and ductal carcinomas with recurrence
    Udo Jeschke
    Department of Obstetrics and Gynaecology, Ludwig Maximilians University of Munich, Maistrasse 11, 80337 Munich, Germany
    Oncol Rep 13:413-9. 2005
    ..In contrast, cases of breast cancer with metastatic infiltration and recurrence show weak expression of glycodelin. On the basis of these results, we speculate that glycodelin could be used as a prognostic marker for breast cancer...
  53. ncbi Characterisation of disseminated tumor cells in the bone marrow of breast cancer patients by the Thomsen-Friedenreich tumor antigen
    Christian Schindlbeck
    First Department of Obstetrics and Gynecology, Ludwig Maximilians University of Munich, Maistrasse 11, 80337, Munich, Germany
    Histochem Cell Biol 123:631-7. 2005
    ..As TF is a specific marker of DTC-BM, it could be used as a target for antibody based therapy and immunomagnetic enrichment techniques for the isolation of DTC-BM...
  54. ncbi Expression of glycodelin in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastases
    Naim Shabani
    I Department of Obstetrics and Gynaecology, Ludwig Maximilians University of Munich, Maistrasse 11, 80337 Munich, Germany
    Anticancer Res 25:1761-4. 2005
    ..Recently, glycodelin was demonstrated to be expressed in normal and cancerous human breast tissue...
  55. ncbi A pooled analysis of bone marrow micrometastasis in breast cancer
    Stephan Braun
    Department of Obstetrics and Gynecology, Innsbruck Medical University, Innsbruck, Austria
    N Engl J Med 353:793-802. 2005
    ..We assessed the prognostic significance of the presence of micrometastasis in the bone marrow at the time of diagnosis of breast cancer by means of a pooled analysis...
  56. ncbi Failure of Implanon contraception in a patient taking carbamazepin for epilepsia
    Christian Schindlbeck
    Frauenklinik, Ludwig Maximilians University, Maistrasse 11, 80337, Munich, Germany
    Arch Gynecol Obstet 273:255-6. 2006
    ..The patient was concurrently taking carbamazepin for epilepsia. Special care should be taken to patients demanding hormonal contraceptives while taking carbamezepin. Even Implanon seems to possibly fail in this combination...
  57. ncbi Detection of micrometastatic disease in bone marrow: is it ready for prime time?
    Wolfgang Janni
    Department of Obstetrics and Gynecology, Ludwig Maximilians University, Munich, Germany
    Oncologist 10:480-92. 2005
    ..However, until clinically relevant data regarding successful therapy of MRD are available, treatment interventions on the basis of MRD should only be performed within clinical trials...
  58. ncbi Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology
    Bernd Gerber
    Department of Obstetrics and Gynecology, Klinikum Innenstadt, Ludwig Maximilians University, Munich, Germany
    Clin Cancer Res 12:1245-50. 2006
    ..To investigate the effect of switching from adjuvant tamoxifen to anastrozole (Arimidex) treatment in postmenopausal women with endocrine-responsive breast cancer and histologically proven tamoxifen-induced benign endometrial pathology...